114932-86-4
79710-86-4
1539417-15-6
1522873-52-4
1495485-96-5
1824186-46-0
171674-76-3 | Ryngo® 1-23 | AA01ENCB
369377-66-2 | L-Proline,L-leucyl-L-a-glutamyl-L-asparaginyl-L-seryl-L-seryl-L-prolyl-L-glutaminyl-L-alanyl-L-prolyl-L-alanyl-L-arginyl-L-arginyl-L-leucyl-L-leucyl-L-prolyl- | AA01ENG3 | MFCD31544499
1415264-56-0 | O-(2-Aminoethyl)-5Z,8Z,11Z,14Z-eicosatetraenoatetrifluoroacetate | AA01ENJ7 | MFCD30182288
1432043-31-6 | N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-4-[(3,5-dihydroxyphenyl)methyl]-1-piperazinecarboxamidedihydrochloride | AA01ENM2 | MFCD19690923
874882-92-5 | 1-[(1-Methylethyl)amino]-3-[2-(1H-pyrrol-1-yl)]-propan-2-olhemifumarate | AA01ENOX | MFCD09878253
1807523-99-4 | IACS-10759 Hydrochloride | AA01EO0D | MFCD31746887
736048-65-0 | PKC-theta inhibitor | AA01EO3C | MFCD31715442
1835705-59-3 | E3 ligase Ligand-Linker Conjugates 9 | AA01EO73 | MFCD31560479
1093131-03-3 | Veledimex S enantiomer | AA01EODU | MFCD31382195
1313730-19-6 | TFLLR-NH2(TFA) | AA01EOIW | MFCD05663482
